Live feed
Filing
SC 13G
SC 13G0001571049-17-001210·Celgene Switzerland LLC
Schedule 13G ownership disclosure
JOUNCE THERAPEUTICS INC
Security class unavailable · CUSIP: 481116101
Event date: 2017-02-01
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001571049-17-001210
- Form type
- SC 13G
- Filer
- Celgene Switzerland LLC
- CIK
- CIK 1661486
- Filed
- Feb 10, 2017
- Reporting period
- Feb 01, 2017
- Description
- Schedule 13G beneficial ownership